成都前列腺肥大医院哪个比较好成都脉管畸形去哪个医院好,河南洛阳血管瘤医院,成都婴儿血管瘤如何做手术,成都哪个血糖足医院比较好,成都治疗脉管畸形医院地图,成都小腿静脉曲张手术治疗,成都雷诺氏症治疗去哪家好

TOKYO, June 19 (Xinhua) -- The Japanese gaming company Sega Corp. said in a statement on Sunday some personal information from more than 1.2 million registered users had been stolen after the website of its subsidiary based in Britain was hacked.The Sega Pass website operated by Sega Europe limited was designed to provide product news. The services were shutdown following the breach detected on Friday. They are still not resumed on the official website of the company late Sunday night and the company said it is investigating the hacking.The company said most of the users of the hacked website are in Europe and North America. A similar cyberattack had troubled the Sony group earlier in April. The hacking affected about 100 million people.

PARIS, June 19 (Xinhua) -- Commercial Aircraft Corporation of China Ltd. (Comac) on Sunday set up its European office in Paris, the second overseas branch after its U.S. office, marking a new step for China's aviation industry in opening-up and international exchanges."The establishment of Comac Europe office is very significant. It represents the strategic cooperation between China and France and will deepen the two sides' collaboration in aerospace and all areas concerned," Chinese Ambassador Kong Quan said at an opening ceremony, citing Europe's influence in global aerospace industry and civil aviation market."Taking self-dependent innovation as the strategic cornerstone, Comac meanwhile actively conducts international cooperation and draws upon advanced technologies and experience in global civil aviation industry...," Comac President Jin Zhuanglong said.French Secretary of State for Transport Thierry Mariani (4th L), Chinese Ambassador to France Kong Quan (3rd L) and General Manager of the Commercial Aircraft Corporation of China (COMAC) Jin Zhuanglong (2nd R) attend the unveiling ceremony of COMAC Europe Office in Paris, France, June 19, 2011. The COMAC Europe Office was offically opened here Sunday.The Chinese aerospace manufacturer has built up cooperative relationship and partnership with dozens of enterprises and institutions in many countries and regions since its establishment in May 2008 in Shanghai.Regional jet ARJ21 and the trunkliner C919 are two flagship products of the young Chinese company. The group is now working to achieve certification and delivery of ARJ21-700 aircraft by the end of this year, Jin said.With regard to China's C919 trunkliner program, Jin said COMAC has signed cooperation agreements with 17 international companies in the United States and Europe, and has actively explored collaboration with GECAS, British Airways and Ryanair."In the context that the world economy is on recovery from the financial crisis, the civil aviation industry is facing great challenge. We are willing to keep close contact with all relevant public administrations and forge friendly relations and cooperation with overseas suppliers to contribute to the development of world civil aviation industry," Jin said.For the French State Secretary for Transport Thierry Marianne, who also attended the opening ceremony, the Chinese aviation market has great potential in the years to come, and China is estimated to need 3,000 new planes."We have understood that China had decided to build its own aerospace industry. It is a legitimate choice," Marianne said.A demo mock-up of the full-scale forward fuselage of C919 will be displayed during the 49th Paris Air Show on June 20-26, which will be the first time that the 1:1 demo mock-up is to be showcased at an international stage outside China, Jin told Xinhua.During the air show, Comac is going to sign agreements with an international airline and an airborne-system supplier and carry out a series of activities concerning international cooperation and exchanges, according to the group.

SYDNEY, Aug. 2 (Xinhua) -- Australia's general practitioners ( GPs) will not back the idea of routine prostate cancer tests for men as young as 40 despite growing calls for regular screening, the nation's largest professional general practice organization said on Tuesday.Spokesman for the Royal Australian College of General Practitioners (RACGP), Professor Chris Del Mar said there was not enough solid evidence to suggest major benefits from routine screening and that current tests were unable to detect "nasty" and potentially deadly forms of prostate cancer from ones that will not cause any harm."The problem is you end up treating lots of people who don't need to be treated," Del Mar said, adding that treatment could leave men impotent and with incontinence problems."You will treat 20 times as many people than would have ever been bothered by it. We don't yet know that treating prostate cancer is better than not treating it. We are not sure it does any good and could be doing more harm," he said.On the other hand, Australia's urologists and pathologists both want men aged 40 and over who are worried about developing the disease to be offered tests.The Royal College of Pathologists (RCPA) on Tuesday released an official recommendation on routine screening for men aged 40 and over if they were concerned about prostate cancer.The pathologists argue that blood tests for prostate cancer in men under 50 can predict their future risk of developing the disease by measuring their prostate specific antigen levels (PSA).They say that men with high PSA levels for their age should be tested annually, while those PSA levels are below the average could be tested less frequently.Their call for more routine testing contrasts with recommendations for GPs, whose `Red Book' medical guide does not support regular screening.Instead, it suggests GPs should inform men aged 50-70 of the risks and benefits of screening and only test if the patient requests one.RACGP spokesman Del Mar, who co-wrote the RACGP's recommendations, said while the Red Book was being revised "we are not going to liberalize it".Prostate cancer is one of the most common forms of cancer in Australia.About 20,000 cases of prostate cancer are diagnosed each year, with 3,300 men dying.Given the debate around prostate cancer tests, the Royal College of Pathologists wants to work with GPs, urologists and other medical organizations to develop a consensus on how and when to test for the disease, in a similar way to how experts approach breast cancer."It would be a good outcome for prostate cancer if we worked towards developing more of an umbrella document which reflected consensus among different stakeholder organizations. ," RCPA President Paul McKenzie said.

BEIJING, July 5 (Xinhuanet) -- Facebook CEO Mark Zuckerberg confirmed that he has signed up to Google+, the new social networking platform from Google, according to media reports Tuesday.Launched last month, Google+ is the Internet giant's latest foray into social networking.Zuckerberg confirmed that the profile with his name on Google+ belongs to him only, and said, "Why are people so surprised that I'd have a Google account?" Facebook CEO Mark Zuckerberg reacts after unveiling a new messaging system during a news conference in San Francisco, California November 15, 2010.In social networking field, it is rare for someone to join the rival's platform, therefore, Zuckerberg's move is considered strange.But interestingly, Zuckerberg has more followers than Google founders Larry Page and Sergey Brin, and even Vic Gundotra, the man behind Google+, with over 21,000 people.Besides Google+, Zuckerberg also has an account on Twitter, though it has not been updated for some time.

BEIJING, Aug. 18 (Xinhua) -- A controlled trial has found that Chinese herbal medicine decoction maxingshigan-yinqiaosan has a similar efficacy to oseltamivir in reducing time to fever resolution in people suffering mild H1N1 influenza virus infections.Carried out by a group of Chinese researchers, headed by Prof. Wang Chen with Beijing Chao-Yang Hospital under the Capital Medical University, the study was published by the famous internal medicine journal Ann Intern Med on Tuesday.Participants of the trial were 410 young adults aged 15 to 59 years with laboratory-confirmed H1N1 influenza.The researchers concluded that both active intervention, alone and in combination, were effective in reducing time to fever resolution in young adults with H1N1 flu, and therefore suggest that maxingshigan-yinqiaosan may be an alternative to oseltamivir.